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Pulmonary artery aneurysm (PAA) is an uncommon entity and is usually congenital in origin or sec-
ondary to pulmonary arterial hypertension. Infections causing PAA are few, tuberculosis and bacterial
infections being the common causative organisms. There have been few cases reported previously, in
which the organism causing PAA was found to be a rare fungus called mucor. Pulmonary mucormycosis
causing PAA is an infrequent and almost fatal complication as most of the diagnosis was made post
mortem.
This report brings out a case of pulmonary mucormycosis causing ruptured PAA in a patient with
diabetes. This patient was cured by a timely treatment of a combination of surgery and medical therapy.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pulmonary artery aneurysm (PAA) is an uncommon entity in a
medical ICU as compared to the more prevalent aortic and intra-
cranial aneurysms [1,2]. Most of them are found incidentally during
radiological investigations in adults and are commonly congenital
in origin. Mycotic or infectious pulmonary artery aneurysms are
rare cause of acquired PAA. These are most commonly caused by
Tuberculosis, syphilis, bacteria like streptococcus and staphylo-
coccus and rarely fungus like actinomycosis and candida [3,4].
There are few scattered published cases describing pulmonary
mucormycosis as causing PAA, with only very few survivals as ante
mortem diagnosis is difﬁcult [5,6]. Pulmonary mucormycosis is a
rare opportunistic infection in patients with severe defects in any
one of the arms of their immune system like diabetes, chronic renal
failure, haematological malignancies, etc. We present a case report
of a successful management of a ruptured PAA caused by mucor-
mycosis in a diabetic patient.
2. Case description
A 58 yr old male, diabetic since 7yrs was presented to the
Emergency Room (ER) with fever, breathlessness, cough and hae-
moptysis for the last two months which had increased in severity
since two days.handran).
Ltd. This is an open access article uOne month back the patient had been evaluated for the above
complaints and a diagnosis of right sided tubercular empyema
(Fig. 1) was made, for which a chest tube drain was inserted and
was prescribed anti tubercular treatment. The inter-costal drain
was removed subsequently a week later and patient was dis-
charged. But, his symptoms recurred and he was brought to our
hospital with worsening of his condition.
In ER, on receiving, the patient was found to be pale, drowsy and
had obvious respiratory distress. He also had features of circulatory
shock with a blood pressure of 60/40 mm of Hg and increased heart
rate of around 150 beats per minute. Immediate resuscitation was
started with intravenous ﬂuids, inotropes and oxygen supple-
mentation by face mask. On examination, he was found to have a
right-sided tension pneumothorax and an ICD was immediately
inserted to decompress it. His general condition gradually
improved. The patient was stabilised and shifted to Medical
Intensive Care Unit (MICU).
A Computed Tomography (CT) of the chest done subsequently
showed a large area of consolidation in the apical segment of right
lower lobe (Fig. 2). He was put on broad spectrum intravenous
antibiotics and his ATT (Anti Tubercular Treatment) was continued.
His condition however did not improve. He continued to remain
tachypneic and had recurrent episodes of massive haemoptysis
(4e5 cupful). Subsequently Computed Tomography Pulmonary
Angiography (CTPA) was done which revealed a saccular aneurysm
involving the distal part of right lower lobar pulmonary artery
measuring 3.1  2.3 cmwith a neck diameter of 4.2 mm suggestive
of Pulmonary Artery Aneurysm (PAA) (Fig. 3).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chest X-ray showing right hydro pneumothorax.
Fig. 2. CT showing collapse consolidation in right lower lobe with cavitation in the
apical segment.
Fig. 3. A saccular aneurysm in the right lower lobar pulmonary artery.
L. Ramachandran et al. / Respiratory Medicine Case Reports 16 (2015) 71e7372Few hours later, the patient suddenly went into respiratory
distress and shock. His trachea was immediately intubated and
mechanical ventilation was initiated. CT chest was done which
showed right sided complete air space opaciﬁcation probably
haemorrhage. Suspecting it to be a ruptured PAA, patient was
immediately shifted to the OT, where laparotomy and right lower
lobe lobectomy with PAA clipping was done. The lobectomy spec-
imen was sent for Histo Pathological Examination. (HPE).
Post operatively, he continued to have fever with rising TLC
(Total Leukocyte Count) counts. He also had frequent recurrent
right middle lobe and upper lobe collapse for which frequent
bronchoscopic suctioning for mucus plug removal was done.
Meanwhile, the HPE report of the lobectomised lung tissue was
reported as invasive mucormycosis (Fig. 4) which was sensitive to
amphotericin. Liposomal Amphotericin B was added at a dose of
200 mg per day (4 mg/kg/day). He responded well to the antifungal
and became afebrile. His TLC counts normalised, oxygenationimproved and there was signiﬁcant radiological Clearance. He was
rapidly weaned off the ventilator and extubated. Post extubation,
he was unable to clear secretions adequately because of his respi-
ratory muscle weakness and poor cough reﬂex. So, on third day of
extubation, he underwent minitracheostomy for adequate clearing
of the secretions. Gradually, with aggressive chest physiotherapy
and regular suctioning, the patient improved andwas subsequently
‘discharged on request’ in a stable condition (with mini-
tracheostomy in situ) to a primary health care centre. Unfortu-
nately, Patient was lost in follow up.
3. Discussion
Pulmonary mucormycosis which was previously found only in
immunocompromised individuals like solid organ transplant re-
cipients, patients on immunosuppressant, haematological malig-
nancies etc., has now emerged as a life-threatening infection in
patients with diabetes in medical ICU [7e9]. Most of the cases are
diagnosed post-mortem, hence early suspicion and detection can
curb the high mortality rate.
Mucormycosis belongs to the genusmucor, order mucorales and
class zygomycetes which survive on decaying organic matter.
Humans are mainly infected through inhalation of the spores [10].
Pulmonary mucormycosis is the second most common form of
human mucormycosis after the rhino-orbital-cerebral form and
presents with fever, chest pain, cough and rapidly progressing
breathlessness and occasionally as life-threatening massive hae-
moptysis [8]. Rarely, it can also present with vocal cord palsy [9].
Radiological examination may show a wedge-shaped lobar
consolidation, cavitation or an air crescent sign which indicates a
life threatening vascular invasion by mucor and requires a prompt
intervention [11]. Its uniqueness lies in its ability to invade the
vessel wall causing thrombophlebitis and thrombosis leading to
large parenchymal infarctions and occasionally, aneurysm and
pseudo aneurysm formations in the pulmonary vascular system [4].
Pulmonary artery aneurysm is the focal dilatation of pulmonary
vessels beyond 29 mm of diameter on CT scan [2,12]. A true
Fig. 4. H & E stained section showing sparsely septate irregular obtuse fungal hyphae
(broken arrows) in a necrotic background (solid arrows). X10X.
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pseudo aneurysm is just a leaking haematoma layered by sur-
rounding soft tissues. PAA are mostly congenital. Acquired forms
are less common and are usually secondary to pulmonary hyper-
tension associated with chronic pulmonary emboli or obstructive
airway disease, mitral stenosis and other veno-occlusive diseases
[13]. Mycotic aneurysms due to infections are very rare and are
mainly associated with tuberculosis (Rossenmuesen aneurysm)
which shows a characteristic peripheral distribution of aneurysms
[14,15]. We believe, in the present case, mucor was directly
responsible for the development of PAA. Mucor had encroached
upon the vessel wall from the surrounding parenchyma causing
inﬂammation and weakening of the vessel wall leading to the
aneurysm formation.
Pulmonary CT angiography is the gold standard to diagnose PAA
[12]. Combination of antifungal with surgical resection of the
involved tissue is the best approach advocated [16]. Surgical
resection is necessary as medical treatment alone has higher
mortality because of the angioinvasive nature of the fungus. Sur-
gical intervention is preferred earlier if the patient presents with
haemoptysis. Surgical modalities now include aneurysectomy, lo-
bectomy or pneumectomy [17]. If the aneurysm does not involve
the main pulmonary trunk, nonsurgical techniques like embolo-
therapy or endovascular coiling is preferred [18].
Liposomal Amphotericin B is the recommended antifungal
agent. The dose and duration of therapy is individualised depend-
ing on the clinical response, clearing in the radiological ﬁndingsand negativity of the cultures. Posaconazole is the alternative drug
against mucorales species for patients who are refractory or intol-
erant to amphotericin therapy [15].
In a nutshell, PAA is a deadly complication of pulmonary
mucormycosis. For early diagnosis, keep a high index of suspicion in
high risk patients like diabetes, chronic renal failure, haemato-
logical malignancies, etc. who are not responding to conservative
management. Lung biopsy and pulmonary angiography to conﬁrm
infection and aneurysm respectively are necessary, when routine
investigations are inconclusive. Multimodality approach combining
medical therapy and surgical or endovascular intervention is the
best approach observed although data available is limited. In our
view, a good post-operative rehabilitation care also contributes to
improved results.References
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